Document is current

Any future updates will be listed below

Correction: Clinical Significance of Prior Ramucirumab Use on the Effectiveness of Nivolumab as the Third-Line Regimen in Gastric Cancer: A Multicenter Retrospective Study

Crossref DOI link: https://doi.org/10.1007/s40801-025-00485-y

Published Online: 2025-03-11

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark